Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint

Breast cancer (BrCa) is the most common malignancy in women and the second most significant cause of death from cancer. BrCa is one of the most challenging malignancies to treat, and it accounts for a large percentage of cancer-related deaths. The number of cases requiring more effective BrCa therap...

Full description

Bibliographic Details
Main Authors: Md. Rezaul Islam, Fahadul Islam, Mohamed H. Nafady, Muniya Akter, Saikat Mitra, Rajib Das, Humaira Urmee, Sheikh Shohag, Aklima Akter, Kumarappan Chidambaram, Fahad A. Alhumaydhi, Talha Bin Emran, Simona Cavalu
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/7/2165
_version_ 1797438403187310592
author Md. Rezaul Islam
Fahadul Islam
Mohamed H. Nafady
Muniya Akter
Saikat Mitra
Rajib Das
Humaira Urmee
Sheikh Shohag
Aklima Akter
Kumarappan Chidambaram
Fahad A. Alhumaydhi
Talha Bin Emran
Simona Cavalu
author_facet Md. Rezaul Islam
Fahadul Islam
Mohamed H. Nafady
Muniya Akter
Saikat Mitra
Rajib Das
Humaira Urmee
Sheikh Shohag
Aklima Akter
Kumarappan Chidambaram
Fahad A. Alhumaydhi
Talha Bin Emran
Simona Cavalu
author_sort Md. Rezaul Islam
collection DOAJ
description Breast cancer (BrCa) is the most common malignancy in women and the second most significant cause of death from cancer. BrCa is one of the most challenging malignancies to treat, and it accounts for a large percentage of cancer-related deaths. The number of cases requiring more effective BrCa therapy has increased dramatically. Scientists are looking for more productive agents, such as organic combinations, for BrCa prevention and treatment because most chemotherapeutic agents are linked to cancer metastasis, the resistance of the drugs, and side effects. Natural compounds produced by living organisms promote apoptosis and inhibit metastasis, slowing the spread of cancer. As a result, these compounds may delay the spread of BrCa, enhancing survival rates and reducing the number of deaths caused by BrCa. Several natural compounds inhibit BrCa production while lowering cancer cell proliferation and triggering cell death. Natural compounds, in addition to therapeutic approaches, are efficient and potential agents for treating BrCa. This review highlights the natural compounds demonstrated in various studies to have anticancer properties in BrCa cells. Future research into biological anti-BrCa agents may pave the way for a new era in BrCa treatment, with natural anti-BrCa drugs playing a key role in improving BrCa patient survival rates.
first_indexed 2024-03-09T11:37:23Z
format Article
id doaj.art-ad4b1f7a56a945f7ab7df8ff1e5f6b7b
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T11:37:23Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-ad4b1f7a56a945f7ab7df8ff1e5f6b7b2023-11-30T23:40:28ZengMDPI AGMolecules1420-30492022-03-01277216510.3390/molecules27072165Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic ViewpointMd. Rezaul Islam0Fahadul Islam1Mohamed H. Nafady2Muniya Akter3Saikat Mitra4Rajib Das5Humaira Urmee6Sheikh Shohag7Aklima Akter8Kumarappan Chidambaram9Fahad A. Alhumaydhi10Talha Bin Emran11Simona Cavalu12Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, BangladeshDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, BangladeshFaculty of Applied Health Science Technology, Misr University for Science and Technology, Giza 12568, EgyptDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, BangladeshDepartment of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, BangladeshDepartment of Pharmaceutical Science, North South University, Dhaka 1229, BangladeshDepartment of Biochemistry and Molecular Biology, Faculty of Life Science, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, BangladeshDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, BangladeshDepartment of Pharmacology and Toxicology, College of Pharmacy, King Khalid University, Abha 62529, Saudi ArabiaDepartment of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi ArabiaDepartment of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, BangladeshFaculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, RomaniaBreast cancer (BrCa) is the most common malignancy in women and the second most significant cause of death from cancer. BrCa is one of the most challenging malignancies to treat, and it accounts for a large percentage of cancer-related deaths. The number of cases requiring more effective BrCa therapy has increased dramatically. Scientists are looking for more productive agents, such as organic combinations, for BrCa prevention and treatment because most chemotherapeutic agents are linked to cancer metastasis, the resistance of the drugs, and side effects. Natural compounds produced by living organisms promote apoptosis and inhibit metastasis, slowing the spread of cancer. As a result, these compounds may delay the spread of BrCa, enhancing survival rates and reducing the number of deaths caused by BrCa. Several natural compounds inhibit BrCa production while lowering cancer cell proliferation and triggering cell death. Natural compounds, in addition to therapeutic approaches, are efficient and potential agents for treating BrCa. This review highlights the natural compounds demonstrated in various studies to have anticancer properties in BrCa cells. Future research into biological anti-BrCa agents may pave the way for a new era in BrCa treatment, with natural anti-BrCa drugs playing a key role in improving BrCa patient survival rates.https://www.mdpi.com/1420-3049/27/7/2165natural compoundsantitumorimmune-suppressivebreast cancercombination therapy
spellingShingle Md. Rezaul Islam
Fahadul Islam
Mohamed H. Nafady
Muniya Akter
Saikat Mitra
Rajib Das
Humaira Urmee
Sheikh Shohag
Aklima Akter
Kumarappan Chidambaram
Fahad A. Alhumaydhi
Talha Bin Emran
Simona Cavalu
Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
Molecules
natural compounds
antitumor
immune-suppressive
breast cancer
combination therapy
title Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
title_full Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
title_fullStr Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
title_full_unstemmed Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
title_short Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint
title_sort natural small molecules in breast cancer treatment understandings from a therapeutic viewpoint
topic natural compounds
antitumor
immune-suppressive
breast cancer
combination therapy
url https://www.mdpi.com/1420-3049/27/7/2165
work_keys_str_mv AT mdrezaulislam naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT fahadulislam naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT mohamedhnafady naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT muniyaakter naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT saikatmitra naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT rajibdas naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT humairaurmee naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT sheikhshohag naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT aklimaakter naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT kumarappanchidambaram naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT fahadaalhumaydhi naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT talhabinemran naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint
AT simonacavalu naturalsmallmoleculesinbreastcancertreatmentunderstandingsfromatherapeuticviewpoint